Immunosuppressants (Monoclonal Antibodies)

NICE Guidance (see also drug specific guidance below)

NICE TA1142: Dupilumab for maintenance treatment of uncontrolled chronic obstructive pulmonary disease with raised blood eosinophils

NICE TA1134: Dupilumab for treating severe chronic rhinosinusitis with nasal polyps

Please refer to the High Cost Drugs Manual.

  • On Formulary Preferred
  • On Formulary Second Line
  • On Formulary Third Line
  • Specialist Initiation
  • Secondary Care Only
  • Not Approved for Formulary